Encompass Health Prices $500M Senior Notes Offering at 5.875%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 14 2026
0mins
Source: seekingalpha
- Financing Size: Encompass Health successfully priced a $500M offering of 5.875% senior notes, priced at 100% of principal value and maturing in 2034, demonstrating strong capital market access.
- Interest Payment Structure: Interest on the notes will be paid semiannually on June 1 and December 1, with the first payment scheduled for December 1, 2026, ensuring stable future cash flows and boosting investor confidence.
- Use of Proceeds: Proceeds will be used to redeem $400M of 4.500% senior notes and repay $100M under the senior secured revolving credit facility, optimizing the capital structure and reducing financial costs.
- Strategic Outlook: Encompass Health raised its 2026 revenue outlook to $6.375B-$6.470B while planning to open seven new hospitals, indicating a proactive strategic approach to business expansion and market share enhancement.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy EHC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on EHC
Wall Street analysts forecast EHC stock price to rise
5 Analyst Rating
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 104.450
Low
134.00
Averages
146.75
High
160.00
Current: 104.450
Low
134.00
Averages
146.75
High
160.00
About EHC
Encompass Health Corporation is an owner and operator of inpatient rehabilitation hospitals in the United States. The Company provides compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and treatments to maximize recovery. It operates hospitals in 38 states and Puerto Rico, with concentrations in Florida and Texas. It operates approximately 166 inpatient rehabilitation hospitals. Its inpatient rehabilitation hospitals offer specialized rehabilitative care across an array of diagnoses and deliver comprehensive patient care services. It provides care to patients who suffer from cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures and a variety of debilitating neurological conditions. Its hospitals have settings for treating the debilitating effects of the COVID-19 virus, such as significant muscle weakness, cognitive impairments, shortness of breath with activity and malnutrition.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
BrightSpring Health Services Raises 2026 Outlook Following Strong Q1 Performance
- Revenue Outlook Raised: BrightSpring has increased its 2026 revenue forecast to $14.725 billion to $15.225 billion, up from the previous range of $14.450 billion to $15.00 billion, indicating strong confidence in future growth, particularly in pharmacy and provider services.
- Profitability Improvement: The adjusted EBITDA range has been lifted to $795 million to $825 million, reflecting management's confidence in margin expansion, which is expected to offset revenue pressures from policy changes through efficiency gains and business integration.
- Strong Q1 Performance: BrightSpring reported adjusted earnings per share of 39 cents in the first quarter, exceeding the market expectation of 29 cents and more than doubling year-over-year, showcasing significant improvements in profitability and market competitiveness.
- Healthy Cash Flow Position: By the end of the first quarter, BrightSpring had $888.8 million in cash and cash equivalents, a substantial increase from $88.4 million in the prior quarter, indicating improved financial flexibility that supports future debt reduction and selective reinvestment.
See More
Encompass Health Prices $500M Senior Notes Offering at 5.875%
- Financing Size: Encompass Health successfully priced a $500M offering of 5.875% senior notes, priced at 100% of principal value and maturing in 2034, demonstrating strong capital market access.
- Interest Payment Structure: Interest on the notes will be paid semiannually on June 1 and December 1, with the first payment scheduled for December 1, 2026, ensuring stable future cash flows and boosting investor confidence.
- Use of Proceeds: Proceeds will be used to redeem $400M of 4.500% senior notes and repay $100M under the senior secured revolving credit facility, optimizing the capital structure and reducing financial costs.
- Strategic Outlook: Encompass Health raised its 2026 revenue outlook to $6.375B-$6.470B while planning to open seven new hospitals, indicating a proactive strategic approach to business expansion and market share enhancement.
See More
Encompass Health Announces Redemption of 4.5% Senior Notes
- Debt Redemption Announcement: Encompass Health has announced the redemption of $400 million of its 4.5% senior notes due 2028, with the redemption price set at 100% of par plus accrued interest, expected to be paid on June 15, 2026.
- Financial Impact: The company anticipates recording an approximate $3.2 million loss on early extinguishment of debt in Q2 2026, which will negatively affect its short-term financial performance.
- Bond Balance Status: As of May 14, 2026, the total outstanding amount of the 2028 senior notes was $800 million, and this redemption will reduce the company's debt burden, despite incurring a loss in the short term.
- Company Background: Encompass Health is the largest operator of inpatient rehabilitation hospitals in the U.S., with 175 facilities providing high-quality rehabilitative care, and despite facing financial challenges, it is recognized as America's Most Awarded Leader in Inpatient Rehabilitation.
See More
Encompass Health Launches $500M Senior Notes Offering
- Bond Offering Initiative: Encompass Health (EHC) has commenced a private offering of $500 million in senior notes due 2034, reflecting the company's proactive financing strategy in the capital markets.
- Guarantee Structure: The notes will be guaranteed on a senior unsecured basis by the company's subsidiaries, which also guarantee its credit agreement and other capital market debts, enhancing the credit rating of the bonds.
- Use of Proceeds: EHC plans to use the proceeds along with available cash to redeem $400 million of its outstanding 4.500% senior notes due 2028 at par, aiming to reduce interest burdens and optimize its capital structure.
- Credit Facility Repayment: Part of the proceeds will also be allocated to repay $100 million outstanding under its senior secured revolving credit facility, further improving the company's liquidity and financial flexibility.
See More
Encompass Health Launches $500 Million Senior Notes Offering
- Bond Offering Announcement: Encompass Health has announced the commencement of a $500 million senior notes offering maturing in 2034, aimed at optimizing its capital structure through market conditions.
- Clear Use of Proceeds: The company intends to use the net proceeds from the bond offering, along with available cash, to redeem $400 million of its 4.5% senior notes due 2028 and repay $100 million of its senior secured revolving credit facility, thereby reducing financial costs.
- Compliance and Market Positioning: The notes will be offered only to qualified institutional buyers and certain non-U.S. persons under Rule 144A of the Securities Act, ensuring compliance and broadening the investor base.
- Strong Company Background: Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the U.S., with 175 hospitals, and is committed to providing high-quality rehabilitative care using advanced technology and innovative treatments, further solidifying its market leadership.
See More
Encompass Health Launches $500 Million Senior Notes Offering
- Bond Offering Announcement: Encompass Health has initiated a $500 million senior notes offering maturing in 2034, aimed at optimizing its capital structure under prevailing market conditions.
- Clear Use of Proceeds: The company intends to use the net proceeds from the bond offering, along with available cash, to redeem $400 million of its outstanding 4.5% senior notes due 2028 and repay $100 million of its senior secured revolving credit facility, thereby reducing financial costs.
- Compliance and Market Positioning: The notes will be offered only to qualified institutional buyers under Rule 144A of the Securities Act, ensuring compliance while broadening the potential investor base.
- Strong Company Background: Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the U.S., with 175 hospitals, enhancing its market competitiveness and brand reputation through high-quality rehabilitative care and advanced technology.
See More
BrightSpring Health Services Raises 2026 Outlook Following Strong Q1 Performance
- Revenue Outlook Raised: BrightSpring has increased its 2026 revenue forecast to $14.725 billion to $15.225 billion, up from the previous range of $14.450 billion to $15.00 billion, indicating strong confidence in future growth, particularly in pharmacy and provider services.
- Profitability Improvement: The adjusted EBITDA range has been lifted to $795 million to $825 million, reflecting management's confidence in margin expansion, which is expected to offset revenue pressures from policy changes through efficiency gains and business integration.
- Strong Q1 Performance: BrightSpring reported adjusted earnings per share of 39 cents in the first quarter, exceeding the market expectation of 29 cents and more than doubling year-over-year, showcasing significant improvements in profitability and market competitiveness.
- Healthy Cash Flow Position: By the end of the first quarter, BrightSpring had $888.8 million in cash and cash equivalents, a substantial increase from $88.4 million in the prior quarter, indicating improved financial flexibility that supports future debt reduction and selective reinvestment.
See More
Encompass Health Prices $500M Senior Notes Offering at 5.875%
- Financing Size: Encompass Health successfully priced a $500M offering of 5.875% senior notes, priced at 100% of principal value and maturing in 2034, demonstrating strong capital market access.
- Interest Payment Structure: Interest on the notes will be paid semiannually on June 1 and December 1, with the first payment scheduled for December 1, 2026, ensuring stable future cash flows and boosting investor confidence.
- Use of Proceeds: Proceeds will be used to redeem $400M of 4.500% senior notes and repay $100M under the senior secured revolving credit facility, optimizing the capital structure and reducing financial costs.
- Strategic Outlook: Encompass Health raised its 2026 revenue outlook to $6.375B-$6.470B while planning to open seven new hospitals, indicating a proactive strategic approach to business expansion and market share enhancement.
See More
Encompass Health Announces Redemption of 4.5% Senior Notes
- Debt Redemption Announcement: Encompass Health has announced the redemption of $400 million of its 4.5% senior notes due 2028, with the redemption price set at 100% of par plus accrued interest, expected to be paid on June 15, 2026.
- Financial Impact: The company anticipates recording an approximate $3.2 million loss on early extinguishment of debt in Q2 2026, which will negatively affect its short-term financial performance.
- Bond Balance Status: As of May 14, 2026, the total outstanding amount of the 2028 senior notes was $800 million, and this redemption will reduce the company's debt burden, despite incurring a loss in the short term.
- Company Background: Encompass Health is the largest operator of inpatient rehabilitation hospitals in the U.S., with 175 facilities providing high-quality rehabilitative care, and despite facing financial challenges, it is recognized as America's Most Awarded Leader in Inpatient Rehabilitation.
See More
Encompass Health Launches $500M Senior Notes Offering
- Bond Offering Initiative: Encompass Health (EHC) has commenced a private offering of $500 million in senior notes due 2034, reflecting the company's proactive financing strategy in the capital markets.
- Guarantee Structure: The notes will be guaranteed on a senior unsecured basis by the company's subsidiaries, which also guarantee its credit agreement and other capital market debts, enhancing the credit rating of the bonds.
- Use of Proceeds: EHC plans to use the proceeds along with available cash to redeem $400 million of its outstanding 4.500% senior notes due 2028 at par, aiming to reduce interest burdens and optimize its capital structure.
- Credit Facility Repayment: Part of the proceeds will also be allocated to repay $100 million outstanding under its senior secured revolving credit facility, further improving the company's liquidity and financial flexibility.
See More
Encompass Health Launches $500 Million Senior Notes Offering
- Bond Offering Announcement: Encompass Health has announced the commencement of a $500 million senior notes offering maturing in 2034, aimed at optimizing its capital structure through market conditions.
- Clear Use of Proceeds: The company intends to use the net proceeds from the bond offering, along with available cash, to redeem $400 million of its 4.5% senior notes due 2028 and repay $100 million of its senior secured revolving credit facility, thereby reducing financial costs.
- Compliance and Market Positioning: The notes will be offered only to qualified institutional buyers and certain non-U.S. persons under Rule 144A of the Securities Act, ensuring compliance and broadening the investor base.
- Strong Company Background: Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the U.S., with 175 hospitals, and is committed to providing high-quality rehabilitative care using advanced technology and innovative treatments, further solidifying its market leadership.
See More
Encompass Health Launches $500 Million Senior Notes Offering
- Bond Offering Announcement: Encompass Health has initiated a $500 million senior notes offering maturing in 2034, aimed at optimizing its capital structure under prevailing market conditions.
- Clear Use of Proceeds: The company intends to use the net proceeds from the bond offering, along with available cash, to redeem $400 million of its outstanding 4.5% senior notes due 2028 and repay $100 million of its senior secured revolving credit facility, thereby reducing financial costs.
- Compliance and Market Positioning: The notes will be offered only to qualified institutional buyers under Rule 144A of the Securities Act, ensuring compliance while broadening the potential investor base.
- Strong Company Background: Encompass Health is the largest owner and operator of inpatient rehabilitation hospitals in the U.S., with 175 hospitals, enhancing its market competitiveness and brand reputation through high-quality rehabilitative care and advanced technology.
See More
